Jubilant Ingrevia's Stock Sees 6.53% Increase, Outperforms Sector and Sensex in One Day

Jubilant Ingrevia, a midcap pharmaceutical company, saw a 6.53% increase in its stock price on April 24, 2024. The stock was given a 'Hold' rating by MarketsMOJO, a leading financial analysis firm.

The stock is currently trading close to its 52-week high of Rs 574.65, with a 1.4% difference. It also outperformed the sector by 5.08% on the same day. Jubilant Ingrevia's stock reached an intraday high of Rs 566.9, a 5.68% increase.

In terms of moving averages, the stock is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates a positive trend in the company's stock performance.

Compared to the overall performance of the Sensex, Jubilant Ingrevia's stock showed a 7.79% increase in just one day, while the Sensex only had a 0.41% increase. In the past month, the stock has also outperformed the Sensex by 25.91%, with a 1.66% increase in the Sensex.

Jubilant Ingrevia's stock performance is a reflection of the company's strong position in the midcap pharmaceutical industry. With its consistent growth and positive outlook, the company continues to be a promising player in the market.